Sign-Up for News
    -Click Here-

   SM Facebook 140x140

  SM Twitter 140x145

PARTNERSHIPS

  

  

  iConquerMS 141x35 small partner banner

   

  

 bionews services

 tannerlogo

 

 

Members

Reset Font Size

Search through our menus for many more articles, videos and presentations.

-----------------------------------------------------------

More Articles...

  1. Preliminary Results of MS Prevalence Study Estimate Nearly 1 Million Living with MS in the U.S.
  2. Repairing Damaged Tissues
  3. Pediatric MS Support
  4. 2017 - Pediatric MS Centers & Specialists - updated
  5. Multiple Sclerosis Risk Significantly Associated With Vitamin D Deficiency
  6. Ask the Expert: Managing Urinary Retention in Multiple Sclerosis
  7. This is a clinical trial for Patients with Urinary Incontinence, who have Multiple Sclerosis…
  8. ACCESS to CARE
  9. Multiple Sclerosis (MS) Treatment Options_Updated May 2017
  10. Considering OCREVUS for PPMS?
  11. Positive Phase III Results of Genentech’s Investigational Medicine Ocrevus™ (Ocrelizumab) Published in New England Journal of Medicine
  12. MAKE your Voice HEARD on MS Treatments
  13. Novartis Helps Raise Greater Awareness of Unique Challenges Faced by Women with MS
  14. Learn about Foot Drop - the cause, symptoms and treatments
  15. Navigate the #TSA checkpoint with #MS
  16. Multiple Sclerosis Patient Resources
  17. Disease Modifying Treatments for Multiple Sclerosis
  18. Possible JC Virus Vaccination Offers Important Implications for MS Treatment
  19. Stem cell news from Hadassah Hospital
  20. MS Views and News - Keeps You Up-to-date and Informed, Digitally
  21. Apr 16, 2015 - FDA approves Glatopa(TM) as the first generic competitor to MS therapy Copaxone® 20mg
  22. STATE of MS REPORT
  23. More Encouraging Results From Stem-Cell Transplants
  24. Multiple Sclerosis 101: Understanding the Nervous System
  25. Prescription Assistance Programs for MS Disease-Modifying Therapies
  26. More than 7,000 Scientists Present Findings at World’s Largest Gathering Dedicated to MS Research
  27. Teriflunomide Is Now the First Oral Regimen Proven to Delay Onset of Clinically Definite Multiple Sclerosis
  28. What Causes MS?
  29. Multiple Sclerosis (MS) SYMPTOMS - Learn to recognize and manage the possible symptoms of MS, which range from mild to severe.
  30. Nanotechnology a Possible Future Solution for Multiple Sclerosis
  31. Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis
  32. How multiple sclerosis is described and understood - redefined by an International committee
  33. Researchers Present Guide To Compassion Fatigue
  34. Multiple sclerosis discovery may explain gender gap
  35. Medical Marijuana: What the Research Shows

Upcoming Events

Nov
27

Nov 27 2017 6:00 pm - 8:30 pm

Nov
28

Nov 28 2017 6:00 pm - 8:30 pm

Dec
2

Dec 2 2017 8:55 am - 3:27 pm

Dec
7

Dec 7 2017 6:00 pm - 7:30 pm

Dec
9

Dec 9 2017 10:50 am - 2:30 pm

Dec
14

Dec 14 2017 6:25 pm - 8:35 pm

Dec
21

Dec 21 2017 6:15 pm - 8:45 pm

Dec
27

Dec 27 2017 6:30 pm - 8:00 pm

Jan
4

Jan 4 2018 6:00 pm - 7:30 pm

Feb
1

Feb 1 2018 6:00 pm - 7:30 pm

Feb
1

Feb 1 2018 9:20 pm - 11:20 pm

Feb
8

Feb 8 2018 6:30 pm - 8:30 pm

Feb
10

Feb 10 2018 11:20 am - 2:30 pm

Feb
22

Feb 22 2018 6:00 pm - 8:30 pm

MS Views and News Award Recipient

Donate & Support

Amount Tooltip $10.00
$25.00
$50.00
$100.00
$250.00
$500.00
$1,000.00
$
Payment method
top